XML 69 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Valuation
6 Months Ended
Jun. 30, 2014
Fair Value Disclosures [Abstract]  
Valuation
Valuation
The following is a description of the valuation methodologies used for the Company's financial instruments.
Level 1 valuation methodologies include the observation of quoted prices (unadjusted) for identical assets or liabilities in active markets, often received from widely recognized data providers.
Level 2 valuation methodologies include the observation of (i) quoted prices for similar assets or liabilities in active markets, (ii) inputs other than quoted prices that are observable for the asset or liability (for example, interest rates and yield curves) in active markets and (iii) quoted prices for identical or similar assets or liabilities in markets that are not active.
Level 3 valuation methodologies include (i) the solicitation of valuations from third parties (typically, pricing services and broker-dealers), (ii) the use of proprietary models that require the use of a significant amount of judgment and the application of various assumptions including, but not limited to, prepayment assumptions and default rate assumptions, and (iii) the assessment of observable or reported recent trading activity. The Company utilizes such information to assign a good faith fair value (the estimated price that would be received to sell an asset or paid to transfer a liability in an orderly transaction at the valuation date) to each such financial instrument.
The Company seeks to obtain at least one third-party indicative valuation for each instrument, and often obtains multiple indicative valuations when available. Third-party valuation providers often utilize proprietary models that are highly subjective and also require the use of a significant amount of judgment and the application of various assumptions including, but not limited to, prepayment assumptions and default rate assumptions. The Company has been able to obtain third-party valuations on the vast majority of the Company's assets and expects to continue to solicit third-party valuations on substantially all of its assets in the future to the extent practical. The Company generally values each financial instrument at the average of third-party valuations received and not rejected as described below. Third-party valuations are not binding on the Company and while the Company generally does not adjust valuations it receives, the Company may challenge or reject a valuation when, based on validation criteria, the Company determines that such valuation is unreasonable or erroneous. Furthermore, the Company may determine, based on validation criteria, that for a given instrument the average of the third-party valuations received does not result in what the Company believes to be fair value, and in such circumstances the Company may override this average with its own good faith valuation. The validation criteria include the use of the Company's own models, recent trading activity in the same or similar instruments, and valuations received from third parties. The Company's valuation process, including the application of validation criteria, is overseen by the Manager's valuation committee. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been used had a ready market for the financial instruments existed and the differences could be material to the consolidated financial statements.
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at June 30, 2014:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash and cash equivalents
 
$
145,032

 
$

 
$

 
$
145,032

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
1,059,901

 
$
36,240

 
$
1,096,141

Private label residential mortgage-backed securities
 

 

 
485,902

 
485,902

Private label commercial mortgage-backed securities
 

 

 
28,047

 
28,047

Commercial mortgage loans
 

 

 
37,415

 
37,415

Residential mortgage loans
 

 

 
23,371

 
23,371

Other asset-backed securities
 

 

 
81,315

 
81,315

Real estate owned
 

 

 
1,641

 
1,641

Total investments, at fair value
 

 
1,059,901

 
693,931

 
1,753,832

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 

 

 
14,162

 
14,162

Credit default swaps on corporate bond indices
 

 
21,682

 

 
21,682

Credit default swaps on asset-backed indices
 

 
3,264

 

 
3,264

Interest rate swaps
 

 
19,422

 

 
19,422

Total return swaps
 

 
24

 

 
24

Swaptions
 

 
662

 

 
662

Futures
 
202

 

 

 
202

Forwards
 

 
52

 

 
52

Total financial derivatives–assets, at fair value
 
202

 
45,106

 
14,162

 
59,470

Repurchase agreements
 

 
30,537

 

 
30,537

Total investments and financial derivatives–assets, at fair value and repurchase agreements
 
$
202

 
$
1,135,544

 
$
708,093

 
$
1,843,839

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(802,666
)
 
$

 
$
(802,666
)
Government debt
 

 
(24,457
)
 

 
(24,457
)
Common stock
 
(25,723
)
 

 

 
(25,723
)
Total investments sold short, at fair value
 
(25,723
)
 
(827,123
)
 

 
(852,846
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(26,883
)
 

 
(26,883
)
Credit default swaps on corporate bonds
 

 
(2,287
)
 

 
(2,287
)
Credit default swaps on asset-backed indices
 

 
(4,680
)
 

 
(4,680
)
Credit default swaps on asset-backed securities
 

 

 
(350
)
 
(350
)
Interest rate swaps
 

 
(12,776
)
 

 
(12,776
)
Total return swaps
 

 
(44
)
 

 
(44
)
Options
 

 
(76
)
 

 
(76
)
Swaptions
 

 
(630
)
 

 
(630
)
Futures
 
(338
)
 

 

 
(338
)
Forwards
 

 
(314
)
 

 
(314
)
Total financial derivatives–liabilities, at fair value
 
(338
)
 
(47,690
)
 
(350
)
 
(48,378
)
Securitized debt(1)
 

 

 
(925
)
 
(925
)
Total investments sold short, financial derivatives–liabilities, and securitized debt, at fair value
 
$
(26,061
)
 
$
(874,813
)
 
$
(1,275
)
 
$
(902,149
)

(1)
The asset subject to the resecuritization had a fair value of $2.3 million as of June 30, 2014, which is included on the Consolidated Schedule of Investments under Principal and Interest Private – Label Securities.
Investments under the Agency residential mortgage-backed securities Level 3 category are investments in Agency interest only RMBS securities. There were no transfers of financial instruments between Level 1, Level 2, or Level 3 during the six month period ended June 30, 2014. The Company's reverse repurchase agreements are carried at cost, which approximates fair value. These liabilities are classified as Level 2 liabilities based on the adequacy of the collateral and their short term nature.
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of June 30, 2014:
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities (1)
$
423,562

 
Market Quotes
 
Non Binding Indicative Price
 
$
1.88

 
$
128.12

 
$
77.52

Other asset-backed securities
78,864

 
Market Quotes
 
Non Binding Indicative Price
 
46.69

 
151.00

 
96.10

Private label residential mortgage-backed securities
61,415

 
Discounted Cash Flows
 
Yield
 
4.1
%
 
16.6
%
 
8.0
%
 
 
 
 
 
Projected Collateral Prepayments
 
7.1
%
 
65.9
%
 
31.9
%
 
 
 
 
 
Projected Collateral Losses
 
5.0
%
 
45.4
%
 
14.0
%
 
 
 
 
 
Projected Collateral Recoveries
 
0.3
%
 
22.0
%
 
8.8
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
14.2
%
 
85.4
%
 
45.3
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
9,710

 
Discounted Cash Flows
 
Yield
 
12.5
%
 
36.6
%
 
20.0
%
 
 
 
 
 
Projected Collateral Losses
 
0.5
%
 
3.0
%
 
1.3
%
 
 
 
 
 
Projected Collateral Recoveries
 
5.4
%
 
14.6
%
 
8.6
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
84.1
%
 
94.1
%
 
90.1
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Other asset-backed securities
2,451

 
Discounted Cash Flows
 
Projected Collateral Prepayments
 
69.4
%
 
69.4
%
 
69.4
%
 
 
 
 
 
Projected Collateral Losses
 
0.2
%
 
0.2
%
 
0.2
%
 
 
 
 
 
Projected Collateral Recoveries
 
1.0
%
 
1.0
%
 
1.0
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
29.4
%
 
29.4
%
 
29.4
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
18,337

 
Market Quotes
 
Non Binding Indicative Price
 
$
14.25

 
$
89.00

 
$
59.26

Performing commercial mortgage loans
20,332

 
Discounted Cash Flows
 
Yield
 
12.7
%
 
18.1
%
 
14.6
%
Non-performing commercial mortgage loans
17,083

 
Discounted Cash Flows
 
Yield
 
10.3
%
 
19.7
%
 
15.5
%
 
 
 
 
 
Months to Resolution
 
7

 
14

 
10

Non-performing residential mortgage loan pools and real estate owned
25,012

 
Discounted Cash Flows
 
Yield
 
6.7
%
 
7.2
%
 
6.9
%
 
 
 
 
 
Months to Resolution
 
7.0

 
29.0

 
14.3

Agency interest only residential mortgage-backed securities
32,922

 
Market Quotes
 
Non Binding Indicative Price
 
$
5.88

 
$
22.12

 
$
13.61

Agency interest only residential mortgage-backed securities
3,318

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(2)
 
441

 
887

 
555

 
 
 
 
 
Projected Collateral Prepayments
 
59.6
%
 
77.4
%
 
69.7
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
22.6
%
 
40.4
%
 
30.3
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
 
 
 
 
 
 
 
 
 
 
 
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
13,812

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
19.1
%
 
56.3
%
 
31.1
%
 
 
 
 
 
Projected Collateral Losses
 
16.1
%
 
48.1
%
 
32.7
%
 
 
 
 
 
Projected Collateral Recoveries
 
7.4
%
 
16.0
%
 
12.4
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
16.1
%
 
42.2
%
 
23.8
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
(1)
Includes securitized debt with a fair value of $0.9 million as of June 30, 2014.
(2)
Shown in basis points.
Third-party non-binding indicative prices are validated by comparing such prices to internally generated prices based on the Company's models and to recent trading activity in the same or similar instruments.
For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR Option Adjusted Spread ("OAS") valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to (b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any interest rate options embedded in the asset. The Company considers the expected timeline to resolution in the determination of fair value for its non-performing commercial and residential loans.
Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2013:
(In thousands)
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
183,489

 
$

 
$

 
$
183,489

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
989,842

 
$
40,504

 
$
1,030,346

Private label residential mortgage-backed securities
 

 

 
580,772

 
580,772

Private label commercial mortgage-backed securities
 

 

 
32,994

 
32,994

Commercial mortgage loans
 

 

 
23,887

 
23,887

Residential mortgage loans
 

 

 
24,062

 
24,062

Other asset-backed securities
 

 

 
38,069

 
38,069

Total investments, at fair value
 

 
989,842

 
740,288

 
1,730,130

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 

 

 
16,646

 
16,646

Credit default swaps on corporate bond indices
 

 
14,273

 

 
14,273

Credit default swaps on asset-backed indices
 

 
4,937

 

 
4,937

Interest rate swaps
 

 
23,553

 

 
23,553

Total return swaps
 

 
4

 

 
4

Options
 

 
251

 

 
251

Total financial derivatives–assets, at fair value
 

 
43,018

 
16,646

 
59,664

Repurchase agreements
 

 
27,962

 

 
27,962

Total investments and financial derivatives–assets, at fair value and repurchase agreements
 
$

 
$
1,060,822

 
$
756,934

 
$
1,817,756

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(811,957
)
 
$

 
$
(811,957
)
Government debt
 

 
(27,288
)
 

 
(27,288
)
Common stock
 
(6,369
)
 

 

 
(6,369
)
Total investments sold short, at fair value
 
(6,369
)
 
(839,245
)
 

 
(845,614
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(24,949
)
 

 
(24,949
)
Credit default swaps on asset-backed indices
 

 
(11,866
)
 

 
(11,866
)
Credit default swaps on asset-backed securities
 

 

 
(350
)
 
(350
)
Interest rate swaps
 

 
(5,064
)
 

 
(5,064
)
Total return swaps
 

 
(67
)
 

 
(67
)
Options
 

 
(84
)
 

 
(84
)
Futures
 
(2,373
)
 

 

 
(2,373
)
Forwards
 

 
(38
)
 

 
(38
)
Total financial derivatives–liabilities, at fair value
 
(2,373
)
 
(42,068
)
 
(350
)
 
(44,791
)
Securitized debt(1)
 

 

 
(983
)
 
(983
)
Total investments sold short, financial derivatives–liabilities, and securitized debt, at fair value
 
$
(8,742
)
 
$
(881,313
)
 
$
(1,333
)
 
$
(891,388
)

(1)
The asset subject to the resecuritization had a fair value of $2.3 million as of December 31, 2013, which is included on the Consolidated Schedule of Investments under Principal and Interest Private – Label Securities.
Investments under the Agency residential mortgage-backed securities Level 3 category are investments in Agency interest only RMBS securities. There were no transfers of financial instruments between Level 1, Level 2, or Level 3 during the year ended December 31, 2013.
The Company's reverse repurchase agreements are carried at cost, which approximates fair value. These liabilities are classified as Level 2 liabilities based on the adequacy of the collateral and their short term nature.
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2013:
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities and Other asset-backed securities(1)
$
550,701

 
Market Quotes
 
Non Binding Indicative Price
 
$
1.80

 
$
110.35

 
$
78.09

Private label residential mortgage-backed securities
67,158

 
Discounted Cash Flows
 
Yield
 
3.8
%
 
20.5
%
 
8.0
%
 
 
 
 
 
Projected Collateral Prepayments
 
6.9
%
 
64.5
%
 
29.7
%
 
 
 
 
 
Projected Collateral Losses
 
4.3
%
 
35.2
%
 
17.4
%
 
 
 
 
 
Projected Collateral Recoveries
 
0.3
%
 
17.1
%
 
9.1
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
14.1
%
 
87.3
%
 
43.8
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
3,480

 
Discounted Cash Flows
 
Yield
 
9.2
%
 
18.2
%
 
13.5
%
 
 
 
 
 
Projected Collateral Losses
 
0.2
%
 
0.2
%
 
0.2
%
 
 
 
 
 
Projected Collateral Recoveries
 
15.4
%
 
15.4
%
 
15.4
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
84.4
%
 
84.4
%
 
84.4
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities and commercial mortgage loans
34,489

 
Market Quotes
 
Non Binding Indicative Price
 
$
14.25

 
$
102.89

 
$
74.24

Performing commercial mortgage loans
8,788

 
Discounted Cash Flows
 
Yield
 
12.7
%
 
12.8
%
 
12.7
%
Non-performing commercial mortgage loans
10,123

 
Discounted Cash Flows
 
Yield
 
15.0
%
 
15.0
%
 
15.0
%
 
 
 
 
 
Months to Resolution
 
5

 
7

 
6

Non-performing residential mortgage loan pools
24,062

 
Discounted Cash Flows
 
Yield
 
7.4
%
 
7.4
%
 
7.4
%
 
 
 
 
 
Months to Resolution
 
16.3

 
16.3

 
16.3

Agency interest only residential mortgage-backed securities
38,783

 
Market Quotes
 
Non Binding Indicative Price
 
$
6.26

 
$
33.77

 
$
14.53

Agency interest only residential mortgage-backed securities
1,721

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(2)
 
349

 
645

 
422

 
 
 
 
 
Projected Collateral Prepayments
 
49.0
%
 
58.1
%
 
51.2
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
41.9
%
 
51.0
%
 
48.8
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Credit default swaps on asset-backed securities
16,296

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
19.3
%
 
59.0
%
 
29.9
%
 
 
 
 
 
Projected Collateral Losses
 
15.5
%
 
47.8
%
 
34.8
%
 
 
 
 
 
Projected Collateral Recoveries
 
8.2
%
 
15.2
%
 
13.1
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
15.7
%
 
41.2
%
 
22.2
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
(1)
Includes securitized debt with a fair value of $1.0 million as of December 31, 2013.
(2)
Shown in basis points.
For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR Option Adjusted Spread ("OAS") valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to (b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any interest rate options embedded in the asset.
Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.
The tables below include a roll-forward of the Company's financial instruments for the three month periods ended June 30, 2014 and 2013 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.
Level 3—Fair Value Measurement Using Significant Unobservable Inputs:
Three Month Period Ended June 30, 2014
(In thousands)
Ending
Balance as of 
March 31, 2014
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers In
and/or Out
of Level 3
 
Ending
Balance as of 
June 30, 2014
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
41,375

 
$
(2,045
)
 
$
135

 
$
(728
)
 
$

 
$
(2,497
)
 
$

 
$
36,240

Private label residential mortgage-backed securities
490,083

 
5,203

 
7,718

 
3,516

 
64,639

 
(85,257
)
 

 
485,902

Private label commercial mortgage-backed securities
32,645

 
147

 
3,518

 
(1,979
)
 
28,400

 
(34,684
)
 

 
28,047

Commercial mortgage loans
44,005

 
521

 
871

 
169

 
3,980

 
(12,131
)
 

 
37,415

Residential mortgage loans
23,566

 

 
359

 
1,214

 
1,695

 
(3,463
)
 

 
23,371

Other asset-backed securities
47,458

 
(812
)
 
450

 
(492
)
 
40,300

 
(5,589
)
 

 
81,315

Real estate owned
97

 

 
(10
)
 
(13
)
 
1,658

 
(91
)
 

 
1,641

Total investments, at fair value
679,229

 
3,014

 
13,041

 
1,687

 
140,672

 
(143,712
)
 

 
693,931

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
15,174

 

 
(467
)
 
586

 
417

 
(1,548
)
 

 
14,162

Total financial derivatives– assets, at fair value
15,174

 

 
(467
)
 
586

 
417

 
(1,548
)
 

 
14,162

Total investments and financial derivatives–assets, at fair value
$
694,403

 
$
3,014

 
$
12,574

 
$
2,273

 
$
141,089

 
$
(145,260
)
 
$

 
$
708,093

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(350
)
 
$

 
$
(20
)
 
$

 
$

 
$
20

 
$

 
$
(350
)
Total financial derivatives– liabilities, at fair value
(350
)
 

 
(20
)
 

 

 
20

 

 
(350
)
Securitized debt:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securitized debt
(983
)
 
(5
)
 

 
1

 
62

 

 

 
(925
)
Total securitized debt
(983
)
 
(5
)
 

 
1

 
62

 

 

 
(925
)
Total financial derivatives– liabilities and securitized debt, at fair value
$
(1,333
)
 
$
(5
)
 
$
(20
)
 
$
1

 
$
62

 
$
20

 
$

 
$
(1,275
)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2014, as well as Level 3 financial instruments disposed of by the Company during the three month period ended June 30, 2014. For Level 3 financial instruments held by the Company at June 30, 2014, change in net unrealized gain (loss) of $6.0 million, $0.6 million, and $1.0 thousand, for the three month period ended June 30, 2014 relate to investments, financial derivatives–assets, and securitized debt, respectively.
Level 3—Fair Value Measurement Using Significant Unobservable Inputs:
Three Month Period Ended June 30, 2013
(In thousands)
Beginning
Balance as of
March 31,
2013
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers In
and/or Out
of Level 3
 
Ending
Balance as of 
June 30, 2013
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
16,228

 
$
(1,132
)
 
$

 
$
68

 
$
12,233

 
$

 
$

 
$
27,397

Private label residential mortgage-backed securities
557,820

 
6,471

 
4,189

 
(6,636
)
 
184,029

 
(51,363
)
 

 
694,510

Private label commercial mortgage-backed securities
5,778

 
41

 
324

 
(771
)
 
24,826

 
(6,292
)
 

 
23,906

Commercial mortgage loans
9,713

 
19

 
482

 
(73
)
 
2,550

 
(5,128
)
 

 
7,563

Other asset-backed securities
11,638

 
(68
)
 
531

 
(820
)
 
36,307

 
(7,748
)
 

 
39,840

Total investments, at fair value
601,177

 
5,331

 
5,526

 
(8,232
)
 
259,945

 
(70,531
)
 

 
793,216

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
26,398

 

 
(542
)
 
1,107

 
42

 
(5,871
)
 

 
21,134

Total financial derivatives– assets, at fair value
26,398

 

 
(542
)
 
1,107

 
42

 
(5,871
)
 

 
21,134

Total investments and financial derivatives–assets, at fair value
$
627,575

 
$
5,331

 
$
4,984

 
$
(7,125
)
 
$
259,987

 
$
(76,402
)
 
$

 
$
814,350

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(2
)
 
$

 
$
(29
)
 
$
(540
)
 
$

 
$
30

 
$

 
$
(541
)
Total financial derivatives– liabilities, at fair value
(2
)
 

 
(29
)
 
(540
)
 

 
30

 

 
(541
)
Securitized debt:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securitized debt
(1,205
)
 
(11
)
 

 
(63
)
 
111

 

 

 
(1,168
)
Total securitized debt
(1,205
)
 
(11
)
 

 
(63
)
 
111

 

 

 
(1,168
)
Total financial derivatives– liabilities and securitized debt, at fair value
$
(1,207
)
 
$
(11
)
 
$
(29
)
 
$
(603
)
 
$
111

 
$
30

 
$

 
$
(1,709
)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2013, as well as Level 3 financial instruments disposed of by the Company during the three month period ended June 30, 2013. For Level 3 financial instruments held by the Company at June 30, 2013, change in net unrealized gain (loss) of $(5.0) million, $1.7 million, $(1.1) million, and $63.0 thousand, for the three month period ended June 30, 2013 relate to investments, financial derivatives–assets, financial derivatives–liabilities, and securitized debt, respectively.
Level 3—Fair Value Measurement Using Significant Unobservable Inputs:
Six Month Period Ended June 30, 2014
(In thousands)
Beginning
Balance as of
December 31,
2013
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers In
and/or Out
of Level 3
 
Ending
Balance as of 
June 30, 2014
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
40,504

 
$
(4,334
)
 
$
170

 
$
23

 
$
2,554

 
$
(2,677
)
 
$

 
$
36,240

Private label residential mortgage-backed securities
580,772

 
10,589

 
31,178

 
(9,336
)
 
154,223

 
(281,524
)
 

 
485,902

Private label commercial mortgage-backed securities
32,994

 
352

 
4,391

 
(464
)
 
66,169

 
(75,395
)
 

 
28,047

Commercial mortgage loans
23,887

 
1,084

 
872

 
(291
)
 
24,004

 
(12,141
)
 

 
37,415

Residential mortgage loans
24,062

 

 
377

 
954

 
1,695

 
(3,717
)
 

 
23,371

Other asset-backed securities
38,069

 
(654
)
 
354

 
56

 
54,187

 
(10,697
)
 

 
81,315

Real estate owned

 

 
(10
)
 
(17
)
 
1,759

 
(91
)
 

 
1,641

Total investments, at fair value
740,288

 
7,037

 
37,332

 
(9,075
)
 
304,591

 
(386,242
)
 

 
693,931

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
16,646

 

 
724

 
(625
)
 
456

 
(3,039
)
 

 
14,162

Total financial derivatives– assets, at fair value
16,646

 

 
724

 
(625
)
 
456

 
(3,039
)
 

 
14,162

Total investments and financial derivatives–assets, at fair value
$
756,934

 
$
7,037

 
$
38,056

 
$
(9,700
)
 
$
305,047

 
$
(389,281
)
 
$

 
$
708,093

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(350
)
 
$

 
$
(39
)
 
$

 
$

 
$
39

 
$

 
$
(350
)
Total financial derivatives– liabilities, at fair value
(350
)
 

 
(39
)
 

 

 
39

 

 
(350
)
Securitized debt:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securitized debt
(983
)
 
(12
)
 

 
(16
)
 
86

 

 

 
(925
)
Total securitized debt
(983
)
 
(12
)
 

 
(16
)
 
86

 

 

 
(925
)
Total financial derivatives– liabilities and securitized debt, at fair value
$
(1,333
)
 
$
(12
)
 
$
(39
)
 
$
(16
)
 
$
86

 
$
39

 
$

 
$
(1,275
)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2014, as well as Level 3 financial instruments disposed of by the Company during the six month period ended June 30, 2014. For Level 3 financial instruments held by the Company at June 30, 2014, change in net unrealized gain (loss) of $6.2 million, $(1.5) million, and $(16.0) thousand, for the six month period ended June 30, 2014 relate to investments, financial derivatives–assets, and securitized debt, respectively.
Level 3—Fair Value Measurement Using Significant Unobservable Inputs:
Six Month Period Ended June 30, 2013
(In thousands)
Ending
Balance as of December 31, 2012
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in
Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers In
and/or Out
of Level 3
 
Ending
Balance as of June 30, 2013
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
6,644

 
$
(2,003
)
 
$

 
$
306

 
$
22,450

 
$

 
$

 
$
27,397

Private label residential mortgage-backed securities
528,366

 
13,112

 
19,790

 
17,383

 
256,862

 
(141,003
)
 

 
694,510

Private label commercial mortgage-backed securities
19,327

 
98

 
(1,124
)
 
2,473

 
37,168

 
(34,036
)
 

 
23,906

Commercial mortgage loans
9,546

 
27

 
482

 
86

 
2,551

 
(5,129
)
 

 
7,563

Other asset-backed securities

 
(117
)
 
531

 
(927
)
 
48,101

 
(7,748
)
 

 
39,840

Total investments, at fair value
563,883

 
11,117

 
19,679

 
19,321

 
367,132

 
(187,916
)
 

 
793,216

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
36,031

 

 
2,709

 
(4,492
)
 
91

 
(13,205
)
 

 
21,134

Total financial derivatives– assets, at fair value
36,031

 

 
2,709

 
(4,492
)
 
91

 
(13,205
)
 

 
21,134

Total investments and financial derivatives–assets, at fair value
$
599,914

 
$
11,117

 
$
22,388

 
$
14,829

 
$
367,223

 
$
(201,121
)
 
$

 
$
814,350

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives– liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(1
)
 
$

 
$
(57
)
 
$
(540
)
 
$

 
$
57

 
$

 
$
(541
)
Total financial derivatives– liabilities, at fair value
(1
)
 

 
(57
)
 
(540
)
 

 
57

 

 
(541
)
Securitized debt:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securitized debt
(1,335
)
 
(20
)
 

 
5

 
182

 

 

 
(1,168
)
Total securitized debt
(1,335
)
 
(20
)
 

 
5

 
182

 

 

 
(1,168
)
Total financial derivatives– liabilities and securitized debt, at fair value
$
(1,336
)
 
$
(20
)
 
$
(57
)
 
$
(535
)
 
$
182

 
$
57

 
$

 
$
(1,709
)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2013, as well as Level 3 financial instruments disposed of by the Company during the six month period ended June 30, 2013. For Level 3 financial instruments held by the Company at June 30, 2013, change in net unrealized gain (loss) of $21.5 million, $(9.1) million, $(1.1) million, and $5.0 thousand for the six month period ended June 30, 2013 relate to investments, financial derivatives–assets, financial derivatives–liabilities, and securitized debt, respectively.